FABP4 and Obesity: Previous studies have demonstrated that circulating FABP4 positively correlated with obesity [14], hypertension [15], dyslipidemia [16], insulin resistance [17], waist circumference [18], and atherosclerosis [19], all of which are traditional risk factors of cardiovascular disease (CVD).